Hana Biosciences, Inc. (HNAB.OB) Reverse Stock Split Becomes Effective Today
Hana Biosciences, Inc., a biopharmaceutical company that focuses on cancer care, has instated a 1 for 4 reverse split of its common stock. The split was previously authorized by stockholders at a special meeting on September 2nd, 2010. As a result of the reverse split, every four shares of Hana's pre-split common stock was automatically reclassified as and combined into one share of post-split common stock. As a result, the number of outstanding shares of common stock is approximately 21.2 million, excluding outstanding stock options and warrants to purchase common stock, and subject to adjustment for fractional shares. The reverse…